Skip to main content

Table 1 Characteristics and results in patients Cohort (n=76)

From: Surgical treatment of esophageal carcinoma with curative intent: analysis of a single center experience

  Overall SCC (n=57) ADC (n=19) P value
Age (years) 60 [46 – 76] 61 [46–76] 57 [46–71] 0,09
Sex     0,78
Male 50 (65,79%) 37 (64,91%) 13 (68,42%)  
Female 26 (34,21%) 20 (35,09%) 6 (31,58%)  
Esophagectomy     0,76
Thoracotomy 64 (84,21%) 49 (85,96%) 15 (78,95%)  
VATS 9 (11,84%) 6 (10,53%) 3 (15,79%)  
Transhiatal 3 (3,95%) 2 (3,51%) 1 (5,26%)  
pT factor     <0,01
T1 10 (13,16%) 5 (8,77%) 5 (26,32%)  
T2 33 (43.42%) 21 (36,84%) 12 (63,16%)  
T3 33 (43,42%) 31 (54,39%) 0  
pN factor     0,02
N0 35 (46,05%) 22 (38,60%) 13 (68,42%)  
N+ 41 (53,95%) 35 (61,4%) 6 (31,58%)  
Stage     0,01
I 9 (11,84%) 5 (8,77%) 4 (21,05%)  
IIA 26 (34,21%) 17 (29,82%) 9 (47,37%)  
IIB 15 (19,74%) 10 (17,54%) 5 (26,32%)  
III 26 (34,21%) 25 (43,86%) 1 (5,26%)  
Induction therapy     0,03
Yes 15 (19,74%) 8 (14,04%) 7 (36,84%)  
No 61 (80,26%) 49 (85,96%) 12 (63,16%)  
Complications     0,56
Pleural effusion 3 (3,94%) 2 (3,51%) 1 (5,26%)  
Vocal cord paresis 2 (2,63%) 2 (3,51%) 0  
Bronchial secretions 4 (5,26%) 3 (5,26%) 1 (5,26%)  
Wound dehiscence 2 (2,63%) 1 (1,75%) 1 (5,26%)  
Anastomotic stenosis 3 (3,94%) 1 (1,75%) 2 (10,53%)  
  1. SCC: Squamous Cell Carcinoma; ADC: AdenoCarcinoma; VATS: Video-Assisted ThoracoScopy.
  2. Continuous data are presented as median [range], categorical data as numbers (percentages).